Clinical Trial Update: A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial for HER2-positive metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms, Cancer of the Breast | Phase 2 | Status: COMPLETED